E
ME Therapeutics Holdings Inc. METX
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Net Income 3.86% 37.39% -240.82% 57.50% 12.86%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -9.46% -44.56% 2,983.56% -95.30% -23.23%
Change in Net Operating Assets -9.09% -119.47% 32.42% 126.02% -1,046.15%
Cash from Operations 3.65% -4.58% -41.95% 61.99% -156.80%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- 100.00% -- --
Issuance of Common Stock -- -100.00% -59.28% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 27.27% -101.67% -58.34% -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -7.64% -151.13% -68.66% 469.75% -1,867.27%
Weiss Ratings